APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Factor VIII Concentrate

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Factor VIII Concentrate Industry Growth and Trends Forecast to 2032

22 December 2025111 pages

Choose your research edition.

Industry ResearchHuman Factor VIII Concentrate Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Factor VIII Concentrate Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Human Factor VIII Concentrate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Factor VIII Concentrate Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Factor VIII Concentrate Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Factor VIII Concentrate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Factor VIII Concentrate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Factor VIII Concentrate include Shandong Taibang Biological Products, Shanghai Xinxing Medicine, Shanghai Raas Corp, Novo Nordisk A/S, Grifols, Pfizer, Hualan Biological, Bayer and SinoCell Tech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Factor VIII Concentrate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Factor VIII Concentrate market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Factor VIII Concentrate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Factor VIII Concentrate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Factor VIII Concentrate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Factor VIII Concentrate Market by Company

Shandong Taibang Biological Products

Shanghai Xinxing Medicine

Shanghai Raas Corp

Novo Nordisk A/S

Grifols

Pfizer

Hualan Biological

Bayer

SinoCell Tech

Shire (Baxter)

Octapharma

NovoNordisk

GC Pharma

CSL

Biogen

Human Factor VIII Concentrate Segment by Type

Blood Extraction

Recombine

Human Factor VIII Concentrate Segment by Application

Von Willebrand's Disease

Congenital Coagulation Factor VIII Deficiency

Acquired Factor VIII Deficiency

Human Factor VIII Concentrate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Factor VIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Factor VIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Factor VIII Concentrate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Factor VIII Concentrate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Factor VIII Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Blood Extraction Table 2. Major Company of Recombine Table 3. Global Human Factor VIII Concentrate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 5. Global Human Factor VIII Concentrate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Factor VIII Concentrate Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Factor VIII Concentrate Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Factor VIII Concentrate Sales by Type (2027-2032) & (k units) Table 10. Global Human Factor VIII Concentrate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Factor VIII Concentrate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Factor VIII Concentrate Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Factor VIII Concentrate Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 15. North America Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 17. Europe Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Factor VIII Concentrate Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Factor VIII Concentrate Sales by Type (2021-2026) & (US$ Million) Table 24. Human Factor VIII Concentrate Industry Trends Table 25. Human Factor VIII Concentrate Industry Drivers Table 26. Human Factor VIII Concentrate Industry Opportunities and Challenges Table 27. Human Factor VIII Concentrate Industry Restraints Table 28. Global Human Factor VIII Concentrate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Factor VIII Concentrate Revenue Market Share by Company (2021-2026) Table 30. Global Human Factor VIII Concentrate Sales by Company (2021-2026) & (k units) Table 31. Global Human Factor VIII Concentrate Sales Share by Company (2021-2026) Table 32. Global Human Factor VIII Concentrate Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Factor VIII Concentrate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Factor VIII Concentrate Major Company Production Sites and Headquarters Table 35. Global Human Factor VIII Concentrate Company, Product Type & Application Table 36. Global Human Factor VIII Concentrate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Factor VIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Factor VIII Concentrate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Factor VIII Concentrate Sales by Region (2021-2026) & (k units) Table 41. Global Human Factor VIII Concentrate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Factor VIII Concentrate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Factor VIII Concentrate Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Factor VIII Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Factor VIII Concentrate Sales by Region (2027-2032) & (k units) Table 46. Global Human Factor VIII Concentrate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Factor VIII Concentrate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Factor VIII Concentrate Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Factor VIII Concentrate Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Factor VIII Concentrate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 52. Global Human Factor VIII Concentrate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Factor VIII Concentrate Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Factor VIII Concentrate Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Factor VIII Concentrate Sales by Application (2027-2032) & (k units) Table 57. Global Human Factor VIII Concentrate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Factor VIII Concentrate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Factor VIII Concentrate Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Factor VIII Concentrate Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 62. North America Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 64. Europe Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Factor VIII Concentrate Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Factor VIII Concentrate Sales by Application (2021-2026) & (US$ Million) Table 71. Shandong Taibang Biological Products Company Information Table 72. Shandong Taibang Biological Products Business Overview Table 73. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio Table 75. Shandong Taibang Biological Products Recent Development Table 76. Shanghai Xinxing Medicine Company Information Table 77. Shanghai Xinxing Medicine Business Overview Table 78. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio Table 80. Shanghai Xinxing Medicine Recent Development Table 81. Shanghai Raas Corp Company Information Table 82. Shanghai Raas Corp Business Overview Table 83. Shanghai Raas Corp Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio Table 85. Shanghai Raas Corp Recent Development Table 86. Novo Nordisk A/S Company Information Table 87. Novo Nordisk A/S Business Overview Table 88. Novo Nordisk A/S Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio Table 90. Novo Nordisk A/S Recent Development Table 91. Grifols Company Information Table 92. Grifols Business Overview Table 93. Grifols Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Grifols Human Factor VIII Concentrate Product Portfolio Table 95. Grifols Recent Development Table 96. Pfizer Company Information Table 97. Pfizer Business Overview Table 98. Pfizer Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Pfizer Human Factor VIII Concentrate Product Portfolio Table 100. Pfizer Recent Development Table 101. Hualan Biological Company Information Table 102. Hualan Biological Business Overview Table 103. Hualan Biological Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Hualan Biological Human Factor VIII Concentrate Product Portfolio Table 105. Hualan Biological Recent Development Table 106. Bayer Company Information Table 107. Bayer Business Overview Table 108. Bayer Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bayer Human Factor VIII Concentrate Product Portfolio Table 110. Bayer Recent Development Table 111. SinoCell Tech Company Information Table 112. SinoCell Tech Business Overview Table 113. SinoCell Tech Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. SinoCell Tech Human Factor VIII Concentrate Product Portfolio Table 115. SinoCell Tech Recent Development Table 116. Shire (Baxter) Company Information Table 117. Shire (Baxter) Business Overview Table 118. Shire (Baxter) Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Shire (Baxter) Human Factor VIII Concentrate Product Portfolio Table 120. Shire (Baxter) Recent Development Table 121. Octapharma Company Information Table 122. Octapharma Business Overview Table 123. Octapharma Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Octapharma Human Factor VIII Concentrate Product Portfolio Table 125. Octapharma Recent Development Table 126. NovoNordisk Company Information Table 127. NovoNordisk Business Overview Table 128. NovoNordisk Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. NovoNordisk Human Factor VIII Concentrate Product Portfolio Table 130. NovoNordisk Recent Development Table 131. GC Pharma Company Information Table 132. GC Pharma Business Overview Table 133. GC Pharma Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. GC Pharma Human Factor VIII Concentrate Product Portfolio Table 135. GC Pharma Recent Development Table 136. CSL Company Information Table 137. CSL Business Overview Table 138. CSL Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. CSL Human Factor VIII Concentrate Product Portfolio Table 140. CSL Recent Development Table 141. Biogen Company Information Table 142. Biogen Business Overview Table 143. Biogen Human Factor VIII Concentrate Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Biogen Human Factor VIII Concentrate Product Portfolio Table 145. Biogen Recent Development Table 146. North America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 148. North America Human Factor VIII Concentrate Sales Market Share by Country (2021-2026) Table 149. North America Human Factor VIII Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Human Factor VIII Concentrate Sales Market Share Forecast by Country (2027-2032) Table 151. North America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Human Factor VIII Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Human Factor VIII Concentrate Market Share by Country (2021-2026) Table 154. North America Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Human Factor VIII Concentrate Market Share Forecast by Country (2027-2032) Table 156. Europe Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 158. Europe Human Factor VIII Concentrate Sales Market Share by Country (2021-2026) Table 159. Europe Human Factor VIII Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Human Factor VIII Concentrate Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Human Factor VIII Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Human Factor VIII Concentrate Market Share by Country (2021-2026) Table 164. Europe Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Human Factor VIII Concentrate Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Human Factor VIII Concentrate Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Human Factor VIII Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Human Factor VIII Concentrate Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Human Factor VIII Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Human Factor VIII Concentrate Market Share by Country (2021-2026) Table 174. Asia-Pacific Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Human Factor VIII Concentrate Market Share Forecast by Country (2027-2032) Table 176. Latin America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 178. Latin America Human Factor VIII Concentrate Sales Market Share by Country (2021-2026) Table 179. Latin America Human Factor VIII Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Human Factor VIII Concentrate Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Human Factor VIII Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Human Factor VIII Concentrate Market Share by Country (2021-2026) Table 184. Latin America Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Human Factor VIII Concentrate Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Human Factor VIII Concentrate Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Human Factor VIII Concentrate Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Human Factor VIII Concentrate Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Human Factor VIII Concentrate Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Human Factor VIII Concentrate Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Human Factor VIII Concentrate Market Share by Country (2021-2026) Table 194. Middle East and Africa Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Human Factor VIII Concentrate Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Human Factor VIII Concentrate Distributors List Table 199. Human Factor VIII Concentrate Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Human Factor VIII Concentrate Image Figure 2. Global Human Factor VIII Concentrate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Factor VIII Concentrate Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Factor VIII Concentrate Sales (2021-2032) & (k units) Figure 5. Blood Extraction Image Figure 6. Global Blood Extraction Sales YoY Growth (2021-2032) & (k units) Figure 7. Recombine Image Figure 8. Global Recombine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Factor VIII Concentrate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Factor VIII Concentrate Market Share by Type 2025 VS 2032 Figure 11. North America Human Factor VIII Concentrate Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Factor VIII Concentrate Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Factor VIII Concentrate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Factor VIII Concentrate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Factor VIII Concentrate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Factor VIII Concentrate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Factor VIII Concentrate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Factor VIII Concentrate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Factor VIII Concentrate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Factor VIII Concentrate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Factor VIII Concentrate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Von Willebrand's Disease Image Figure 24. Global Von Willebrand's Disease Sales YoY Growth (2021-2032) & (k units) Figure 25. Congenital Coagulation Factor VIII Deficiency Image Figure 26. Global Congenital Coagulation Factor VIII Deficiency Sales YoY Growth (2021-2032) & (k units) Figure 27. Acquired Factor VIII Deficiency Image Figure 28. Global Acquired Factor VIII Deficiency Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Human Factor VIII Concentrate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Factor VIII Concentrate Market Share by Application 2025 VS 2032 Figure 31. North America Human Factor VIII Concentrate Sales Market Share in Volume by Application in 2025 Figure 32. North America Human Factor VIII Concentrate Sales Market Share in Value by Application in 2025 Figure 33. Europe Human Factor VIII Concentrate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Human Factor VIII Concentrate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Human Factor VIII Concentrate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Human Factor VIII Concentrate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Human Factor VIII Concentrate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Human Factor VIII Concentrate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Human Factor VIII Concentrate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Human Factor VIII Concentrate Sales Market Share in Value by Application in 2025 Figure 41. North America Human Factor VIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Human Factor VIII Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Human Factor VIII Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Human Factor VIII Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Factor VIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Human Factor VIII Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Factor VIII Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Human Factor VIII Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Factor VIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Human Factor VIII Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Factor VIII Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Human Factor VIII Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Factor VIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Human Factor VIII Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Factor VIII Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Factor VIII Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Factor VIII Concentrate Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Human Factor VIII Concentrate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Factor VIII Concentrate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Human Factor VIII Concentrate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Human Factor VIII Concentrate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Human Factor VIII Concentrate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Von Willebrand's Disease
  • Congenital Coagulation Factor VIII Deficiency
  • Acquired Factor VIII Deficiency
Companies covered
  • Shandong Taibang Biological Products
  • Shanghai Xinxing Medicine
  • Shanghai Raas Corp
  • Novo Nordisk A/S
  • Grifols
  • Pfizer
  • Hualan Biological
  • Bayer
  • SinoCell Tech
  • Shire (Baxter)
  • Octapharma
  • NovoNordisk
  • GC Pharma
  • CSL
  • Biogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Factor VIII Concentrate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Factor VIII Concentrate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Factor VIII Concentrate Market by Type
  6. 1.3.1 Blood Extraction
  7. 1.3.2 Recombine
  8. 1.4 Global Human Factor VIII Concentrate Market Size by Type
  9. 1.4.1 Global Human Factor VIII Concentrate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Factor VIII Concentrate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Factor VIII Concentrate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Factor VIII Concentrate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Factor VIII Concentrate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Factor VIII Concentrate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Factor VIII Concentrate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Factor VIII Concentrate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Factor VIII Concentrate Industry Trends
  2. 2.2 Human Factor VIII Concentrate Industry Drivers
  3. 2.3 Human Factor VIII Concentrate Industry Opportunities and Challenges
  4. 2.4 Human Factor VIII Concentrate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Factor VIII Concentrate Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Factor VIII Concentrate Sales (2021-2026)
  3. 3.3 Global Top Players by Human Factor VIII Concentrate Price (2021-2026)
  4. 3.4 Global Human Factor VIII Concentrate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Factor VIII Concentrate Major Company Production Sites & Headquarters
  6. 3.6 Global Human Factor VIII Concentrate Company, Product Type & Application
  7. 3.7 Global Human Factor VIII Concentrate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Factor VIII Concentrate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Factor VIII Concentrate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Factor VIII Concentrate Tier 1, Tier 2, and Tier 3
4 Human Factor VIII Concentrate Regional Status and Outlook
  1. 4.1 Global Human Factor VIII Concentrate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Factor VIII Concentrate Historic Market Size by Region
  3. 4.2.1 Global Human Factor VIII Concentrate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Factor VIII Concentrate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Factor VIII Concentrate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Factor VIII Concentrate Forecasted Market Size by Region
  7. 4.3.1 Global Human Factor VIII Concentrate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Factor VIII Concentrate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Factor VIII Concentrate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Factor VIII Concentrate by Application
  1. 5.1 Human Factor VIII Concentrate Market by Application
  2. 5.1.1 Von Willebrand's Disease
  3. 5.1.2 Congenital Coagulation Factor VIII Deficiency
  4. 5.1.3 Acquired Factor VIII Deficiency
  5. 5.2 Global Human Factor VIII Concentrate Market Size by Application
  6. 5.2.1 Global Human Factor VIII Concentrate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Factor VIII Concentrate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Factor VIII Concentrate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Factor VIII Concentrate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Factor VIII Concentrate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Factor VIII Concentrate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Factor VIII Concentrate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Factor VIII Concentrate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shandong Taibang Biological Products
  2. 6.1.1 Shandong Taibang Biological Products Company Information
  3. 6.1.2 Shandong Taibang Biological Products Business Overview
  4. 6.1.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio
  6. 6.1.5 Shandong Taibang Biological Products Recent Developments
  7. 6.2 Shanghai Xinxing Medicine
  8. 6.2.1 Shanghai Xinxing Medicine Company Information
  9. 6.2.2 Shanghai Xinxing Medicine Business Overview
  10. 6.2.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio
  12. 6.2.5 Shanghai Xinxing Medicine Recent Developments
  13. 6.3 Shanghai Raas Corp
  14. 6.3.1 Shanghai Raas Corp Company Information
  15. 6.3.2 Shanghai Raas Corp Business Overview
  16. 6.3.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio
  18. 6.3.5 Shanghai Raas Corp Recent Developments
  19. 6.4 Novo Nordisk A/S
  20. 6.4.1 Novo Nordisk A/S Company Information
  21. 6.4.2 Novo Nordisk A/S Business Overview
  22. 6.4.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio
  24. 6.4.5 Novo Nordisk A/S Recent Developments
  25. 6.5 Grifols
  26. 6.5.1 Grifols Company Information
  27. 6.5.2 Grifols Business Overview
  28. 6.5.3 Grifols Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Grifols Human Factor VIII Concentrate Product Portfolio
  30. 6.5.5 Grifols Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Human Factor VIII Concentrate Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Hualan Biological
  38. 6.7.1 Hualan Biological Company Information
  39. 6.7.2 Hualan Biological Business Overview
  40. 6.7.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio
  42. 6.7.5 Hualan Biological Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Human Factor VIII Concentrate Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 SinoCell Tech
  50. 6.9.1 SinoCell Tech Company Information
  51. 6.9.2 SinoCell Tech Business Overview
  52. 6.9.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio
  54. 6.9.5 SinoCell Tech Recent Developments
  55. 6.10 Shire (Baxter)
  56. 6.10.1 Shire (Baxter) Company Information
  57. 6.10.2 Shire (Baxter) Business Overview
  58. 6.10.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio
  60. 6.10.5 Shire (Baxter) Recent Developments
  61. 6.11 Octapharma
  62. 6.11.1 Octapharma Company Information
  63. 6.11.2 Octapharma Business Overview
  64. 6.11.3 Octapharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Octapharma Human Factor VIII Concentrate Product Portfolio
  66. 6.11.5 Octapharma Recent Developments
  67. 6.12 NovoNordisk
  68. 6.12.1 NovoNordisk Company Information
  69. 6.12.2 NovoNordisk Business Overview
  70. 6.12.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio
  72. 6.12.5 NovoNordisk Recent Developments
  73. 6.13 GC Pharma
  74. 6.13.1 GC Pharma Company Information
  75. 6.13.2 GC Pharma Business Overview
  76. 6.13.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 GC Pharma Human Factor VIII Concentrate Product Portfolio
  78. 6.13.5 GC Pharma Recent Developments
  79. 6.14 CSL
  80. 6.14.1 CSL Company Information
  81. 6.14.2 CSL Business Overview
  82. 6.14.3 CSL Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CSL Human Factor VIII Concentrate Product Portfolio
  84. 6.14.5 CSL Recent Developments
  85. 6.15 Biogen
  86. 6.15.1 Biogen Company Information
  87. 6.15.2 Biogen Business Overview
  88. 6.15.3 Biogen Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biogen Human Factor VIII Concentrate Product Portfolio
  90. 6.15.5 Biogen Recent Developments
7 North America by Country
  1. 7.1 North America Human Factor VIII Concentrate Sales by Country
  2. 7.1.1 North America Human Factor VIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Factor VIII Concentrate Sales by Country (2021-2026)
  4. 7.1.3 North America Human Factor VIII Concentrate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Factor VIII Concentrate Market Size by Country
  6. 7.2.1 North America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Factor VIII Concentrate Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Factor VIII Concentrate Sales by Country
  2. 8.1.1 Europe Human Factor VIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Factor VIII Concentrate Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Factor VIII Concentrate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Factor VIII Concentrate Market Size by Country
  6. 8.2.1 Europe Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Factor VIII Concentrate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Factor VIII Concentrate Sales by Country
  2. 9.1.1 Asia-Pacific Human Factor VIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Factor VIII Concentrate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Factor VIII Concentrate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Factor VIII Concentrate Market Size by Country
  6. 9.2.1 Asia-Pacific Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Factor VIII Concentrate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Factor VIII Concentrate Sales by Country
  2. 10.1.1 South America Human Factor VIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Factor VIII Concentrate Sales by Country (2021-2026)
  4. 10.1.3 South America Human Factor VIII Concentrate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Factor VIII Concentrate Market Size by Country
  6. 10.2.1 South America Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Factor VIII Concentrate Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Factor VIII Concentrate Sales by Country
  2. 11.1.1 Middle East and Africa Human Factor VIII Concentrate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Factor VIII Concentrate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Factor VIII Concentrate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Factor VIII Concentrate Market Size by Country
  6. 11.2.1 Middle East and Africa Human Factor VIII Concentrate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Factor VIII Concentrate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Factor VIII Concentrate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Factor VIII Concentrate Value Chain Analysis
  2. 12.1.1 Human Factor VIII Concentrate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Factor VIII Concentrate Production Mode & Process
  7. 12.2 Human Factor VIII Concentrate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Factor VIII Concentrate Distributors
  10. 12.2.3 Human Factor VIII Concentrate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst